Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2001035926) AN IMPROVED PHARMACEUTICAL COMPOSITION FOR TREATING MALE ERECTILE DYSFUNCTION
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2001/035926 International Application No.: PCT/IN2000/000105
Publication Date: 25.05.2001 International Filing Date: 24.10.2000
Chapter 2 Demand Filed: 04.06.2001
IPC:
A61K 9/00 (2006.01) ,A61K 31/519 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519
ortho- or peri-condensed with heterocyclic rings
Applicants:
VALLABHANENI, Ramakrishna, Rao [IN/IN]; IN (UsOnly)
NATCO PHARMA LIMITED [IN/IN]; Natco House Road No. 2 Banjara Hills Hyderabad 500 033, IN (AllExceptUS)
Inventors:
VALLABHANENI, Ramakrishna, Rao; IN
Priority Data:
1128/MAS/9918.11.1999IN
Title (EN) AN IMPROVED PHARMACEUTICAL COMPOSITION FOR TREATING MALE ERECTILE DYSFUNCTION
(FR) COMPOSITION PHARMACEUTIQUE AMELIOREE POUR TRAITER LA DYSERECTION MASCULINE
Abstract:
(EN) The invention disclosed in this application relates to a novel pharmaceutical composition containing sildenafil useful for nasal administration for the treatment of male erectile dysfunction due to organic, psychogenic and mixed causes. The composition is also effective in patients with erectile dysfunction due to spinal cord injury. The pharmaceutical composition of the present invention is in the form of a solution or a colloidal dispersion in a pharmaceutical vehicle filled into specially designed dosing device for nasal administration. The invention disclosed in this application also provides a method for preparing the pharmaceutical composition containing sildenafil for nasal application for the treatment of male erectile dysfunction.
(FR) La présente invention concerne une nouvelle composition pharmaceutique à base de sildénafil administrée par voie nasale pour traiter la dysérection masculine d'origines diverses, et notamment organique et psychogène. Cette composition est également efficace chez les patients souffrant de dysérection due à une lésion de la moelle épinière. par ailleurs, cette composition pharmaceutique se présente sous forme de solution ou de dispersion colloïdale contenue dans un excipient pharmaceutique et logée dans un doseur spécialement conçu pour l'administration par voie nasale. En outre, cette invention concerne un procédé de préparation d'une composition pharmaceutique à base de sildénafil devant être administrée par voie nasale en vue de traiter la dysérection masculine.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)